GE HealthCare Technologies (NASDAQ:GEHC) Posts Quarterly Earnings Results, Beats Expectations By $0.19 EPS

GE HealthCare Technologies (NASDAQ:GEHC) issued its quarterly earnings results on Thursday. The company reported $1.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.19, Zacks reports. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. GE HealthCare Technologies updated its FY 2025 guidance to 4.610-4.750 EPS.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $92.21 on Friday. The company has a market capitalization of $42.13 billion, a price-to-earnings ratio of 25.33, a P/E/G ratio of 2.93 and a beta of 1.15. The firm’s 50 day simple moving average is $84.03 and its 200 day simple moving average is $85.51. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. GE HealthCare Technologies has a fifty-two week low of $74.51 and a fifty-two week high of $94.80.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 14th were given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.15%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date of this dividend was Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.85%.

Analyst Ratings Changes

Several research analysts recently issued reports on GEHC shares. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company upped their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday. Finally, Citigroup upped their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday. One analyst has rated the stock with a sell rating, three have issued a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $97.85.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.